Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Great benefit to simple syphilis screening in pregnant women
(June 12, 2012 - Insidermedicine) From London - Syphilis screening ...
(June 12, 2012 - Insidermedicine) From London - Syphilis screening during pregnancy can greatly improve rates of stillbirth and neonatal death across the world, according to a report published in PLoS Medicine. Researchers found that administering a simple point-of-care screening test at rural clinics in 6 low and middle income countries enabled over 100,000 pregnant women to get screened and treated for syphilis. The disease causes over 500,000 stillbirths and neonatal deaths every year.
-
HD
New risk model may be better than Duke Clinical Score in predicting heart disease
(June 12, 2012 - Insidermedicine) From the Netherlands - A ...
(June 12, 2012 - Insidermedicine) From the Netherlands - A new risk score can improve prediction of heart disease in patients with chest pain, according to a report published in the BMJ. Studying data on over 5,600 chest pain patients with no history of heart disease, researchers found that a model that accounted for diabetes, high blood pressure, lipid levels, smoking history, as well as coronary calcium score, significantly improved prediction of heart disease when compared to the currently recommended risk score
-
HD
Mental decline in the elderly is not slowed by omega 3 supplementation
(June 12, 2012 - Insidermedicine) From London - Research published ...
(June 12, 2012 - Insidermedicine) From London - Research published in the Cochrane Database of Systematic Reviews questions if omega-3 prevents mental decline in older adults. Results of a meta-analysis covering over 3,500 older adults found that those taking omega 3 supplements had no reduced risk of cognitive decline when compared to those who took placebo.
-
HD
Omega-3 does not prevent mental decline in older adults; New risk score for heart disease; Syphilis screening can greatly reduce stillbirths, newborn death
(June 12, 2012 - Insidermedicine) From London - Research published ...
(June 12, 2012 - Insidermedicine) From London - Research published in the Cochrane Database of Systematic Reviews questions if omega-3 prevents mental decline in older adults. Restults of a meta-analysis covering over 3,500 older adults found that those taking omega 3 supplements had no reduced risk of cognitive decline when compared to those who took placebo. From the Netherlands - A new risk score can improve prediction of heart disease in patients with chest pain, according to a report published in the BMJ. Studying data on over 5,600 chest pain patients with no history of heart disease, researchers found that a model that accounted for diabetes, high blood pressure, lipid levels, smoking history, as well as coronary calcium score, significantly improved prediction of heart disease when compared to the currently recommended risk score. From London - Syphilis screening can greatly improve rates of stillbirth and neonatal death across the world, according to a report published in PLoS Medicine. Researchers found that administering a simple point-of-care screening test at rural clinics in 6 low and middle income countries enabled over 100,000 women to get screened and treated for syphilis. The disease causes over 500,000 stillbirths and neonatal deaths every year.
-
HD
Insulin use does not cause heart disease, cancer
(June 11, 2012 - Insidermedicine) From Hamilton - A new ...
(June 11, 2012 - Insidermedicine) From Hamilton - A new report published in the NEJM finds no connection between long term insulin use and heart disease or cancer. Researchers randomized nearly 13,000 adults in the early stages of type 2 diabetes or at high risk of the disease to either daily insulin or no insulin at all. After 6 years of followup, researchers found no difference in risk of heart attack, stroke, or cancer between the two groups.
-
HD
Smoking significantly raises risk of death
(June 11, 2012 - Insidermedicine) From Germany - Smoking raises ...
(June 11, 2012 - Insidermedicine) From Germany - Smoking raises risk of all-cause mortality, according to a report published in the Archives of Internal Medicine. Results of a meta-analysis examining 17 studies over the past 25 years found that current smokers were at 2x increased risk of all-cause mortality and former smokers were at 1.3x increased risk.
-
HD
Medication raises risk of diabetic macular edema
(June 11, 2012 - Insidermedicine) From the UK - Thiazolidinedione ...
(June 11, 2012 - Insidermedicine) From the UK - Thiazolidinedione treatment raises risk of a serious eye condition in type 2 diabetics, according to a report published in the Archives of Internal Medicine. Researchers retrospectively studied over 100,000 type 2 diabetic patients and found that treatment with the glucose-lowering medications were associated with increased risk of diabetic macular edema at 1 and 10 year followup.
-
HD
Risk of heart attack rises with elevated blood sugar levels
(June 11, 2012 - Insidermedicine) From Denmark - Even a ...
(June 11, 2012 - Insidermedicine) From Denmark - Even a slight increase in blood glucose levels raises risk of heart attack, according to a report published in the Journal of the American College of Cardiology. Examining data on over 80,000 adults, researchers found that, over time, blood glucose levels that were 1mmol per litre above normal raised risk of heart attack by 69%.
-
HD
High blood glucose linked to risk of heart attack; Thiazolidinedione raises risk of diabetic eye condition; Smokers 2x more likely to die from any cause
(June 11, 2012 - Insidermedicine) From Denmark - Even a ...
(June 11, 2012 - Insidermedicine) From Denmark - Even a slight increase in blood glucose levels raises risk of heart attack, according to a report published in the Journal of the American College of Cardiology. Examining data on over 80,000 adults, researchers found that, over time, blood glucose levels that were 1mmol per litre above normal raised risk of heart attack by 69%. From the UK - Thiazolidinedione treatment raises risk of a serious eye condition in type 2 diabetics, according to a report published in the Archives of Internal Medicine. Researchers retrospectively studied over 100,000 type 2 diabetic patients and found that treatment with the glucose-lowering medications was associated with increased risk of diabetic macular edema at 1 and 10 year followup From Germany - Smoking raises risk of all-cause mortality, according to a report published in the Archives of Internal Medicine. Results of a meta-analysis examining 17 studies over the past 25 years found that current smokers were at 2x increased risk of all-cause mortality and former smokers were at 1.3x increased risk
-
HD
Fruits, vegetables aid smoking cessation
(June 8, 2012 - Insidermedicine) From Buffalo - Fruits and ...
(June 8, 2012 - Insidermedicine) From Buffalo - Fruits and vegetables may help smokers quit, according to a report published in Nicotine and Tobacco Research. Studying 1,000 smokers for 14 months, researchers found that those who ate the most fruits and vegetables were 3x more likely to be tobacco-free for at least a month when compared to those who ate the least.
